139 related articles for article (PubMed ID: 37407446)
41. Phorbol 12-myristate 13-acetate-induced endocytosis of the Na-K-2Cl cotransporter in MDCK cells is associated with a clathrin-dependent pathway.
Mykoniatis A; Shen L; Fedor-Chaiken M; Tang J; Tang X; Worrell RT; Delpire E; Turner JR; Matlin KS; Bouyer P; Matthews JB
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C85-97. PubMed ID: 19864322
[TBL] [Abstract][Full Text] [Related]
42. Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.
Kambayashi S; Minami K; Ogawa Y; Hamaji T; Hwang CC; Igase M; Hiraoka H; Miyama TS; Noguchi S; Baba K; Mizuno T; Okuda M
Can J Vet Res; 2015 Jul; 79(3):201-9. PubMed ID: 26130852
[TBL] [Abstract][Full Text] [Related]
43. p53 expression in canine lymphoma.
Sokołowska J; Cywińska A; Malicka E
J Vet Med A Physiol Pathol Clin Med; 2005 May; 52(4):172-5. PubMed ID: 15882401
[TBL] [Abstract][Full Text] [Related]
44. BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.
Kong W; Sender S; Taher L; Villa-Perez S; Ma Y; Sekora A; Ruetgen BC; Brenig B; Beck J; Schuetz E; Junghanss C; Nolte I; Murua Escobar H
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884478
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma.
Kambayashi S; Igase M; Kobayashi K; Kimura A; Shimokawa Miyama T; Baba K; Noguchi S; Mizuno T; Okuda M
J Vet Med Sci; 2015 Nov; 77(11):1405-12. PubMed ID: 26050843
[TBL] [Abstract][Full Text] [Related]
46. An initial characterisation of the Unfolded Protein Response pathway in haematopoietic canine cancer cell lines - a necessary step for the future development of new therapies in dogs with neoplasia.
Hernández-Suárez B; Gillespie DA; Obmińska-Mrukowicz B; Pawlak A
J Vet Res; 2023 Sep; 67(3):447-458. PubMed ID: 37818142
[TBL] [Abstract][Full Text] [Related]
47. 6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells.
Flesner BK; Kumar SR; Bryan JN
BMC Vet Res; 2014 Dec; 10():290. PubMed ID: 25480665
[TBL] [Abstract][Full Text] [Related]
48. Canine CD20 gene.
Kano R; Inoiue C; Okano H; Yamazaki J; Takahashi T; Watari T; Tokuriki M; Hasegawa A
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):265-8. PubMed ID: 16061290
[TBL] [Abstract][Full Text] [Related]
49. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.
Kirchhausen T; Macia E; Pelish HE
Methods Enzymol; 2008; 438():77-93. PubMed ID: 18413242
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
[TBL] [Abstract][Full Text] [Related]
51. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
[TBL] [Abstract][Full Text] [Related]
52. Canine Bcl-xL gene and its expression in tumor cell lines.
Sano J; Oguma K; Kano R; Hasegawa A
J Vet Med Sci; 2003 Jan; 65(1):149-51. PubMed ID: 12576724
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells.
Bernard S; Poon AC; Tam PM; Mutsaers AJ
BMC Vet Res; 2021 Dec; 17(1):382. PubMed ID: 34895222
[TBL] [Abstract][Full Text] [Related]
54. Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines.
Ema Y; Igase M; Takeda Y; Yanase T; Umeki S; Hiraoka H; Okuda M; Mizuno T
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():95-106. PubMed ID: 25623777
[TBL] [Abstract][Full Text] [Related]
55. Characterization of SET/I2PP2A isoforms in dogs.
Yabe R; Fujiwara N; Mizuno T; Usui T; Ohama T; Sato K
J Vet Med Sci; 2014 Sep; 76(9):1235-40. PubMed ID: 24897959
[TBL] [Abstract][Full Text] [Related]
56. Dynasore inhibition on productive infection of HIV-1 in commonly used cell lines is independent of transferrin endocytosis.
Song H; DeSantis M; Tian C; Cheng W
Matters (Zur); 2018; 2018():. PubMed ID: 31058179
[TBL] [Abstract][Full Text] [Related]
57. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
[TBL] [Abstract][Full Text] [Related]
58. The in vitro effects of piroxicam and meloxicam on canine cell lines.
Knottenbelt C; Chambers G; Gault E; Argyle DJ
J Small Anim Pract; 2006 Jan; 47(1):14-20. PubMed ID: 16417605
[TBL] [Abstract][Full Text] [Related]
59. Targeting NEDD8-activating enzyme is a new approach to treat canine diffuse large B-cell lymphoma.
Assumpção ALFV; Lu Z; Marlowe KW; Shaffer KS; Pan X
Vet Comp Oncol; 2018 Dec; 16(4):606-615. PubMed ID: 30101447
[TBL] [Abstract][Full Text] [Related]
60. The effects of oncolytic reovirus in canine lymphoma cell lines.
Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
